Quillichew ER 20 MG chew tab 100S
Ended Awarded
- Contract number
- SPE2DR26FFF7P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,011
Award facts
- Contract value 100% obligated
- $1,010.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) valued at $1,010.70. This firm fixed-price delivery order, with an ultimate completion date of October 30, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, which serves as the primary distribution hub for AmerisourceBergen's federal pharmaceutical operations.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. Quillichew ER, a brand-name attention deficit hyperactivity disorder medication, represents the type of specialty pharmaceutical products that AmerisourceBergen routinely delivers through its DLA contract portfolio, supporting the medical needs of the armed forces and military beneficiaries worldwide.
Quick answers
Who was awarded contract SPE2DR26FFF7P?
SPE2DR26FFF7P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DR26FFF7P worth?
The government has obligated $1,011 on SPE2DR26FFF7P.
Is contract SPE2DR26FFF7P an order under another contract?
Yes. SPE2DR26FFF7P is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFF7P competed?
The extent of competition for SPE2DR26FFF7P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award